Xiangxue Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xiangxue Pharmaceutical Co Ltd with three other
companies in this sector in China:
Anhui Fengyuan Pharmaceutical
sales of 1.55 billion Chinese Renmimbi [US$223.95 million]
of which 59%
was Medicine Retail Circulation),
Guilin Sanjin Pharmaceutical Co Ltd
(1.37 billion Chinese Renmimbi [US$197.72 million]
of which 96%
was Proprietary Chinese medicine), and
Shanghai Kaibao Pharmaceutical Company Limited
(1.40 billion Chinese Renmimbi [US$201.15 million]
of which 100%
During the year ended December of 2015, sales at
Xiangxue Pharmaceutical Co Ltd were 1.46 billion Chinese Renmimbi (US$210.94 million).
decrease of 3.9%
versus 2014, when the company's sales were 1.52 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 18.8% decline
in Medical Apparatus and Instruments, from 45.01 million Chinese Renmimbi to 36.53 million Chinese Renmimbi.
There were also decreases in sales in
Pharmaceutical Manufacturing (down 10.0% to 775.54 million Chinese Renmimbi)
Pharmaceutical Distribution (down 9.9% to 158.66 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Chinese Herbal Medicines (up 15.4% to 395.26 million Chinese Renmimbi)
Beverage (up 15.2% to 84.61 million Chinese Renmimbi)
Other Operations (up 13.2% to 14.01 million Chinese Renmimbi)